-
REFINE-MS trial, a multi-centre, phase 3 study led by Professor Olga Ciccarelli and Professor Max Parmar at UCL. The trial aims to identify the optimal dosing frequency of ocrelizumab in patients with
-
beneficial. They must have demonstrated ability for creative, original independent research. The person must be adept at multi-tasking and organising their work to meet deadlines. They must have a proven track record of working in multi-disciplinary teams Customer advert reference: B04-07962
-
for a highly motivated, creative, and independently thinking Research Fellow with advanced AI specialist skills, with experience of applying these in a clinical ophthalmic setting. The post holder will
-
demonstrated ability to design and conduct research independently, and be organised, creative, and collaborative. Experience in integrating multiple data types to address biological questions, is highly